| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |